New structured care pathway aims to ease symptoms in advanced cancer
NCT ID NCT07469761
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a structured, symptom-driven care pathway improves symptom control and satisfaction for adults with advanced cancer receiving outpatient palliative care. 120 participants will be randomly assigned to either standard care or a tailored pathway that triggers specific interventions based on patient-reported symptom scores. The goal is to reduce symptom burden and distress, and improve care experience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
structured palliative care pathway
What this could lead to
If it works, this could lead to better symptom control and higher satisfaction with care for people with advanced cancer.
What could go wrong
This is a small, early-stage trial (120 participants) testing a care process, not a new drug. Results may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Istituto Nazionale dei Tumori, Via Venezian n1
RECRUITINGMilan, Lombardy, 20133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••